"10.1371_journal.pone.0119067","plos one","2015-03-06T00:00:00Z","Shannon D Shields; Richard P Butt; Sulayman D Dib-Hajj; Stephen G Waxman","Department of Neurology and Center for Neuroscience and Regeneration Research, Yale University School of Medicine, New Haven, Connecticut, United States of America; Neusentis UK, Pfizer Global R&D, Cambridge, United Kingdom; Rehabilitation Research Center, Veterans’ Affairs Connecticut Healthcare System, West Haven, Connecticut, United States of America","Conceived and designed the experiments: SDS SDD-H SGW. Performed the experiments: SDS. Analyzed the data: SDS RPB SDD-H SGW. Contributed reagents/materials/analysis tools: RPB. Wrote the paper: SDS RPB SDD-H SGW.","SDD-H: consultancy, Ono Pharmaceuticals, Guidepoint Global, Cardiome Pharm; patents, Yale University; stock/stock options, Pfizer. SGW: consultancy, Bristol Myers Squibb, Vertex Pharmaceuticals, ChromoCell Corp, DaiNippon Sumitomo Pharm, Cardiome Pharm; patents, Yale University. RPB is an employee of Pfizer Ltd. Patents held by Dr. Sulayman D. Dib-Hajj and Dr. Dr. Stephen G. Waxman through Yale University are: US Patent 6,573,067: Nucleic acid encoding sodium channels in dorsal root ganglia. European Union patent 05015946.6: Modulation of sodium channels in dorsal root ganglia. This does not alter the authors’ adherence to PLOS ONE policies on sharing data and materials.","2015","03","Shannon D Shields","SDS",4,TRUE,3,1,4,4,TRUE,TRUE,FALSE,0,NA,FALSE
